Sona Nanotech Inc C.SONA

Y’all see this? ...

[JimmyD]

https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-announces-license-columbia-university-rapid-site

[TheModernAge]

Antibody. Next

[bluebeard123]

Sounds like strong competition for Sona. Dont know how far along they are with validation and commercialization. Sona's first to market advantage with high selection activity and sensitivity test may only be a few weeks. Sona needs to have field results out soon.

[2049Dekker]

This test needs an incubator, faster test than before but not portable.Nothing changes here.

[zoe18]

And it is not approve...

[zoe18]

The cosest we get to the EUA authorisation the harder it will get...we are very competitive with best product!

[zoe18]

Like it has been said...This is the hard/fun part

[whatdoiknow123]

Sounds interesting but: 1. No mention of 3rd party Validation so we don´t know how long before submission to FDA 2. No mention of cost 3. Needs enzymes and reagents- how readily available are they for a ramp-up? 4. Needs water bath or incubator. Difficult to see thousands of those at airports, sports stadiums, etc. 5. Diagram shows an exact temperature of 63 degrees. How flexible is that

[bluebeard123]

The larger point is this. ...there is competition out there. There are too many posters here who slam any competition. There is urgency to meeting business objectives or the sona advantage of new and better technology will be lost. Sona is priced on meeting very high FUTURE expectations. Its share price is very high as it has no revenues.

[whatdoiknow123]

  This test does indeed need to be run at a CONSTANT TEMPERATURE of 63 degrees and so needs an ACCURATE INCUBATOR which does rather limit its´ ability to be a Mass Screening tool

[TheeRook]

FDA already looking at it.    Test is just licensed from Columbia University, so it already works since Columbia U uses it internally and at the Hospital. If U know how to warm up water U can use this test.   Simliar tests used in Africa for Zika and Ebola.     Next up is Sorrento's COVI-TRACK test, an in vitro antibody test for COVID-19 that the company

[TheeRook]

  This is one of the Next GEN Technologies .    Used before in the Zika and ebola outbreaks.    A game changer especially for universities  and the world especially resources short poor countries.   Rutgers University and Uiversity of Pittsburgh ,U- Illinois,  UChicago   have similiar saliva tests,  some have already

[Devious66]

Sona will never be able to supply the demand they have anyway so I could care less it there was another test or 2 on the market just as good.  It won't matter cause there is enough demand for everyone to make money 

[Findingmoney]

Sona can license out the tech to manufactures that wish to participate such as Oberon, I am sure when the writing is on the wall, they will come calling for their piece of the Action. From every country and in most of the regions that have not the ability to test due to lack of facilities, to those that need it in very short turn around time. I think they have got that worked out for each stage as

[bluebeard123]

The first to market a low sensitivity, high accuracy test with tracing gets the premium in the market, that is highest share price. After that its commoditized. If you dont think that, then you should sell your shares because that is how Sona is currently priced. In other words, you should be worried about competition.

[dart321]

LOL, it's number that mean everything, numbers tell you where the stock is going, not competition, number, sales, gross sales per share, 100 million test kits sold at $25 per is 2.5 billion dollars or $41 per share gross. That tells you where this is heading nothing else !!!!!

[wallpaper2]

I read where your calculations said  "every 5 million units sold translated into $15-$16 per share." So 100 million would work out to 20x$15.50= $310 per share. Am I  reading this wrong. Are we now at $41/share on the sale of 100 million kits?

[dart321]

5 million units sold @$25 = aprox $2.07 per share in gross sales. 100 million units sold @$25= aprox $41 per share in gross sales. What you have to do now is look at what the margins are, what the sector multiples are then do the math to come up with an approximate valuation.

[burnout29]

This post has been removed in accordance with Community Policy

[dart321]

and you are not going to see one that is correct until we know what the real sales numbers are, what the real margins are and any other additional costs charged against sales, untl then it's ball park figures. These are estimates and would only be valid if these field tests confirm MRIGlobals numbers.

[burnout29]

This post has been removed in accordance with Community Policy

[shoosh22]

Haha I missed the whole afternoon yesterday... I only looked later and saw the $12.60 close..didn't notice it dipped to $10. something until this morning.... Glad I missed the panic.  I would have been pi..ed!  lol  She is gonna come back strong!

[whatdoiknow123]

The tests you refer to need to be sent to  LABS for processing and therefore they cannot be compared to SONA tests